middle.news
Next Science Narrows Losses as Asset Sale Clears Path Forward
3:49am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Next Science Narrows Losses as Asset Sale Clears Path Forward
3:49am on Saturday 30th of August, 2025 AEST
Key Points
Product sales decline 7% to US$10.5 million
Direct sales of XPERIENCE surge 54%, offsetting other declines
Adjusted EBITDA loss improves 42% to -US$2.8 million
Shareholders approve sale of majority assets to OSARTIS GmbH
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NXS
OPEN ARTICLE